OverviewChartNewsTraderScreen

Emisphere Technologies/  US2913451066  /

Nasdaq Other OTC
2020-12-08  12:00:00 AM Chg. - Volume Bid- Ask- High Low
7.8100USD - 184,515
Turnover: -		 -Bid Size: - -Ask Size: - 7.8200 7.8000
GlobeNewswire 2020-12-08 Novo Nordisk Completes Acquisition of Emisphere Technologies for $1.35 Billion
GlobeNewswire 2020-12-01 SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, an...
GlobeNewswire 2020-11-20 SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, LBRT, TNAV, an...
GlobeNewswire 2020-11-12 SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Emisphere Technologies, Inc. Bu...
GlobeNewswire 2020-11-10 Emisphere Technologies, Inc. (OTC:EMIS) INVESTOR NOTICE: Abraham, Fruchter & Twersky, LLP Is Investi...
GlobeNewswire 2020-11-09 EMISPHERE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of EMIS and Encourages Investors to C...
GlobeNewswire 2020-11-06 Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion
TeleTrader 2020-11-06 Novo Nordisk buying Emisphere Tech for $1.8B
GlobeNewswire 2020-07-14 Recce Pharmaceuticals Adds Biotech Veteran Alan W. Dunton M.D. to its Board of Directors
GlobeNewswire 2020-04-06 EMISPHERE DEVELOPMENT UPDATE
GlobeNewswire 2019-11-18 RenovaCare Appoints Alan L. Rubino as President and CEO
GlobeNewswire 2019-10-01 Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
GlobeNewswire 2019-09-20 Emisphere Development Update
GlobeNewswire 2019-09-10 Emisphere Announces Leadership Changes
GlobeNewswire 2019-04-26 Emisphere Development Update
GlobeNewswire 2019-03-20 Emisphere Development Update
GlobeNewswire 2018-08-28 Emisphere’s Proprietary Eligen Technology Supports Novo Nordisk’s Oral Semaglutide
GlobeNewswire 2018-06-29 Emisphere Development Update
GlobeNewswire 2018-06-21 Emisphere Development Update
GlobeNewswire 2018-06-21 Bioavailability Enhancement Technologies and Services Market, 2030
GlobeNewswire 2018-05-31 Emisphere Development Update
GlobeNewswire 2018-05-30 ELIGEN B12 Receives “Amazon’s Choice” Designation
GlobeNewswire 2018-05-16 Oral Proteins and Peptides Market, 2030
GlobeNewswire 2018-04-26 Emisphere Amends License Agreement with Novo Nordisk
GlobeNewswire 2018-03-01 Iovance Biotherapeutics Appoints Michael Weiser, M.D., Ph.D., to its Board of Directors